High-dose immunosuppressive therapy for rheumatoid arthritis: Some answers, more questions

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2269-2274

  McSweeney, Peter A ^a   Furst, Daniel E ^b   West, Sterling G ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

AUTOIMMUNITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RELAPSE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033510137     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2269::AID-ANR2>3.0.CO;2-Z     Document Type: Editorial

References (30)